Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > January 9th warrants

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jan 06, 2023 3:57pm

197 Views

Post# 35207791

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrants

@CancerSlayer, Agreed. Let's hope the 450 assessments were all completed before end of year, and that the clinical data study is completed in the near future so they can submit to FDA sooner instead of later.

<< Previous

Bullboard Posts

Next >>

NTG Clarity Networks' growth story continues with $22M contract